← Back
$HRTX All transactions

HERON THERAPEUTICS, INC. /DE/

A

$ Value

$0

Shares

53,960

Price

$0

Filed

Feb 3

Insider

Name

Dissanaike Sharmila

Title

CIK

0001885069

Roles

Director

Transaction Details

Transaction Date

2026-01-30

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

53,960

Footnotes

The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.

Filing Info

Accession No.

0001193125-26-034626

Form Type

4

Issuer CIK

0000818033

Dissanaike Sharmila's History

Date Ticker Type Value
2026-01-30 HRTX A $0

Other Insiders at HRTX (90d)

Insider Bought Sold Last
Forbes William P
EVP, Chief Development Officer
2026-04-19
Collard Craig A
Chief Executive Officer
2026-04-19
Johnson Craig A 2026-01-30
Duarte Ira
EVP, Chief Financial Officer
2026-04-19
Christian Waage 2026-01-30
Kaseta Michael 2026-01-30
Morgan Adam 2026-01-30
Hensley Mark Earl
Chief Operating Officer
2026-01-30
Cusack Thomas 2026-01-30